Journal List > J Rheum Dis > v.19(6) > 1064005

Choi, Ku, Kwon, Park, and Kim: A Case of Localized Castleman's Disease in a Patient with Rheumatoid Arthritis

Abstract

Castleman's disease is an atypical lymphoproliferative disorder of unknown origin. It has three histologic types (hyaline vascular, plasma-cell, and mixed) and two clinical types (localized and multicentric). Some systemic diseases may be accompanied with Castleman's disease, but it is unclear if Castleman's disease is relevant to rheumatoid arthritis. We experienced a case of Castleman's disease suffering from rheumatoid arthritis. A 25-year-old female with rheumatoid arthritis was referred to our hospital with a palpable mass lesion in the left upper arm. Excisional biopsy of the mass and arthroscopic synovectomy were performed, and the histological finding was compatible with hyaline-vascular type of Castleman's disease. Herein, we report this case along with brief review of relevant literature.

Figures and Tables

Figure 1
(A~C) Ultrasonographic findings of left elbow joint and mass lesion: (A) Synovial hypertrophy with increased vascularity of the left elbow joint, (B, C) Benign natured lymph node with an intact capsule and no abnormal vascularity. (D) Light microscopic findings of mass lesion shows proliferation of lymphoid tissue forming large follicles, containing increased vascular proliferation and hyalinization of their germinal centers. The mass lesion is a giant lymphoid hyperplasia, and is compatible with hyaline-vascular type (H&E, ×200).
jrd-19-351-g001

References

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956. 9:822–830.
2. Krishnan J, Danon AD, Frizzera G. Reactive lymphadenopathies and atypical lymphoproliferative disorders. Am J Clin Pathol. 1993. 99:385–396.
3. Frizzera G. Castleman's disease: more questions than answers. Hum Pathol. 1985. 16:202–205.
4. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972. 29:670–683.
5. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol. 1992. 5:525–530.
6. Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc. 1995. 70:969–977.
7. Neerhout RC, Larson W, Mansur P. Mesenteric lymphoid hamartoma associated with chronic hypoferremia, anemia, growth failure and hyperglobulinemia. N Engl J Med. 1969. 280:922–925.
8. Frizzera G. Knowles DM, editor. Atypical lymphoproliferative disorders. Neoplastic Hematopathology. 1992. Baltimore: Williams & Wilkins;454–495.
9. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol. 1988. 5:346–364.
10. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989. 74:1360–1367.
11. Beck JT, Hsu SM, Wijdenes J, Bataille R, Klein B, Vesole D, et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994. 330:602–605.
12. Samoszuk M, Ramzi E, Ravel J. Disseminated persistent lymphoid hyperplasia containing Epstein-Barr virus and clonal rearrangements of DNA. Diagn Mol Pathol. 1993. 2:57–60.
13. Nunna SV, Sharma R, Goyal M, Berry M, Gupta SD, Deshpande V. Unusual computed tomography appearance of Castleman disease. Australas Radiol. 1997. 41:193–195.
14. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol. 1985. 16:162–172.
15. Parez N, Bader-Meunier B, Roy CC, Dommergues JP. Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr. 1999. 158:631–637.
TOOLS
Similar articles